Interest and intention to use long-acting injectable PrEP for HIV (LA-PrEP) among MSM and trans people in the Netherlands – results from the PROTECT survey

AUTHORS

J. Kolstee¹, H. Wang¹, H. Zimmermann¹, A. Adriaque Lozano¹, M. Schroeder², A. Appiah², C. Brown³, K. Jonas¹


INSTITUTIONS

¹Maastricht University, Maastricht, Netherlands, the, ²ViiV Healthcare Ltd, Brentford, United Kingdom, ³ViiV Healthcare Ltd, Durham, United States